Knott David M Jr
- SEC CIK
- 0001892770
Holdings, Q2 2026
Positions as of Jun 30, 2026, filed Aug 12, 2026.SEC
- Positions
- 84
- −1 vs. Q1 2026
- Total value
- $189.18M
- +$21.14M (+12.6%) vs. Q1 2026
Compare with Q1 2026: new, added, reduced and sold out
Positions
Long positions only. Changes compare share counts with Q1 2026.
| Security | Class | Shares | Value | % of portfolio | Change in shares | Action | History |
|---|---|---|---|---|---|---|---|
| GOOGALPHABET INC CAP STK CL C | Stock | 91,420 | $32.3M | 17.07% | 00.0% | Unchanged | View |
| APOAPOLLO GLOBAL MGMT INC | COM | 225,000 | $26.62M | 14.07% | 00.0% | Unchanged | View |
| SNDXSYNDAX PHARMACEUTICALS INC | COM | 437,245 | $9.56M | 5.05% | +15,245+3.6% | Added | View |
| XERSXERIS BIOPHARMA HOLDINGS INC | COM | 1,060,000 | $8.4M | 4.44% | 00.0% | Unchanged | View |
| TVTXTRAVERE THERAPEUTICS INC | COM | 147,282 | $8.37M | 4.42% | +6,649+4.7% | Added | View |
| PTGXPROTAGONIST THERAPEUTICS INC | COM | 63,000 | $7.72M | 4.08% | 00.0% | Unchanged | View |
| BBIOBRIDGEBIO PHARMA INC | COM | 92,850 | $6.92M | 3.66% | +2,850+3.2% | Added | View |
| IOVAIOVANCE BIOTHERAPEUTICS INC | COM | 1,600,000 | $6.66M | 3.52% | 00.0% | Unchanged | View |
| ALKSALKERMES PLC | SHS | 121,759 | $6.38M | 3.37% | +1,759+1.5% | Added | View |
| JPMJPMORGAN CHASE & CO COM | Stock | 18,098 | $5.92M | 3.13% | −1,379−7.1% | Reduced | View |
| JANUS DETROIT STR TR47103U845 | HENDRSON AAA CL | 93,528 | $4.72M | 2.50% | 00.0% | Unchanged | – |
| LPLALPL Financial Holdings Inc. | Common | 16,500 | $4.65M | 2.46% | 00.0% | Unchanged | View |
| COGTCOGENT BIOSCIENCES INC | COM | 111,081 | $4.3M | 2.27% | +7,081+6.8% | Added | View |
| TGTXTG THERAPEUTICS INC | COM | 66,839 | $3.67M | 1.94% | −23,162−25.7% | Reduced | View |
| CLSTCATALYST BANCORP INC | COMMON STOCK | 114,000 | $3.58M | 1.89% | +114,000 | New | View |
| AGIOAGIOS PHARMACEUTICALS INC | COM | 95,058 | $3.53M | 1.86% | +2,000+2.1% | Added | View |
| VRDNVIRIDIAN THERAPEUTICS INC | COM | 181,000 | $3.32M | 1.76% | 00.0% | Unchanged | View |
| RLMDRELMADA THERAPEUTICS INC | COM | 451,000 | $3.12M | 1.65% | +11,700+2.7% | Added | View |
| RCUSARCUS BIOSCIENCES INC | COM | 81,241 | $2.5M | 1.32% | 00.0% | Unchanged | View |
| HELPCYBIN INC | COM NEW | 370,000 | $2.45M | 1.29% | +20,000+5.7% | Added | View |
| STATE STREET SPDR S&P BIOTECH ETF78464A870 | ETF | 15,000 | $2.37M | 1.25% | 00.0% | Unchanged | – |
| RZLTREZOLUTE INC | COM NEW | 370,000 | $1.92M | 1.02% | 00.0% | Unchanged | View |
| ABALLIANCEBERNSTEIN HLDG L P | UNIT LTD PARTN | 48,000 | $1.69M | 0.89% | 00.0% | Unchanged | View |
| MDGLMADRIGAL PHARMACEUTICALS INC | COM | 3,000 | $1.61M | 0.85% | +1,000+50.0% | Added | View |
| ATRCATRICURE INC | COM | 51,400 | $1.44M | 0.76% | 00.0% | Unchanged | View |
| DCGODOCGO INC | COM | 2,670,850 | $1.38M | 0.73% | 00.0% | Unchanged | View |
| ARDXARDELYX INC | COM | 263,168 | $1.34M | 0.71% | +56,168+27.1% | Added | View |
| RAREULTRAGENYX PHARMACEUTICAL IN | COM | 38,069 | $1.27M | 0.67% | +5,000+15.1% | Added | View |
| SERIES PORTFOLIOS TR81752T528 | ELDRIDGE BBB B | 47,807 | $1.26M | 0.67% | 00.0% | Unchanged | – |
| CGEMCULLINAN THERAPEUTICS INC | COM | 69,182 | $1.26M | 0.67% | +44,982+185.9% | Added | View |
| JNJJOHNSON & JOHNSON COM | Stock | 4,922 | $1.25M | 0.66% | 00.0% | Unchanged | View |
| VERAVERA THERAPEUTICS INC | CL A | 26,000 | $1.12M | 0.59% | 00.0% | Unchanged | View |
| OBIOORCHESTRA BIOMED HLDGS INC | COM | 253,651 | $1.09M | 0.58% | 00.0% | Unchanged | View |
| SPRBSPRUCE BIOSCIENCES INC | COM NEW | 20,000 | $1.08M | 0.57% | +20,000 | New | View |
| CNTBCONNECT BIOPHARMA HLDGS LTD | SHS | 444,862 | $1.06M | 0.56% | +57,027+14.7% | Added | View |
| ISHARES TR464287556 | ISHARES BIOTECH | 5,500 | $1.05M | 0.55% | 00.0% | Unchanged | – |
| BIIBBIOGEN INC | COM | 4,000 | $864.24K | 0.46% | 00.0% | Unchanged | View |
| PFEPFIZER INC COM | Stock | 32,337 | $778.68K | 0.41% | 00.0% | Unchanged | View |
| AAPLAPPLE INC COM | Stock | 2,494 | $721.66K | 0.38% | 00.0% | Unchanged | View |
| CNQCANADIAN NAT RES LTD MED TER | COM | 16,800 | $663.6K | 0.35% | 00.0% | Unchanged | View |
| PTHSPELTHOS THERAPEUTICS INC | COM SHS | 22,073 | $623.78K | 0.33% | +1,000+4.7% | Added | View |
| IBMINTERNATIONAL BUSINESS MACHS COM | Stock | 2,142 | $602.35K | 0.32% | 00.0% | Unchanged | View |
| MSFTMICROSOFT CORP COM | Stock | 1,600 | $596.83K | 0.32% | 00.0% | Unchanged | View |
| VSTMVERASTEM INC | COM NEW | 155,000 | $592.1K | 0.31% | +51,000+49.0% | Added | View |
| KURAKURA ONCOLOGY INC | COM | 52,767 | $578.85K | 0.31% | 00.0% | Unchanged | View |
| SLDBSOLID BIOSCIENCES INC | COM NEW | 56,208 | $561.52K | 0.30% | +9,065+19.2% | Added | View |
| DDDuPont de Nemours, Inc. | Common | 3,767 | $510.96K | 0.27% | +3,767 | New | View |
| INSMINSMED INC | COM PAR $.01 | 4,253 | $453.46K | 0.24% | +4,253 | New | View |
| LBRXLB PHARMACEUTICALS INC | COM SHS | 12,965 | $420.78K | 0.22% | +12,965 | New | View |
| CDNACAREDX INC | COM | 13,630 | $388.46K | 0.21% | +13,630 | New | View |
| QTTBQ32 BIO INC | COM | 30,412 | $387.45K | 0.20% | +30,412 | New | View |
| ELVNENLIVEN THERAPEUTICS INC | COM | 6,183 | $313.79K | 0.17% | +6,183 | New | View |
| RHPRYMAN HOSPITALITY PPTYS INC | COM | 2,400 | $308.52K | 0.16% | 00.0% | Unchanged | View |
| AVGOBROADCOM INC COM | Stock | 710 | $268.2K | 0.14% | 00.0% | Unchanged | View |
| KMBKIMBERLY-CLARK CORP COM | Stock | 2,400 | $263.45K | 0.14% | 00.0% | Unchanged | View |
| NVDANVIDIA CORPORATION COM | Stock | 1,280 | $256.12K | 0.14% | 00.0% | Unchanged | View |
| BSXBOSTON SCIENTIFIC CORP COM | Stock | 6,000 | $256.08K | 0.14% | +6,000 | New | View |
| WVEWAVE LIFE SCIENCES LTD | SHS | 40,000 | $232.4K | 0.12% | 00.0% | Unchanged | View |
| RAINRAIN ENHANCEMENT TECHNOLOGIE | CL A | 101,686 | $210.49K | 0.11% | 00.0% | Unchanged | View |
| MDLZMONDELEZ INTL INC CL A | Stock | 3,000 | $173.52K | 0.09% | 00.0% | Unchanged | View |
| PWRQUANTA SVCS INC | COM | 176 | $126.73K | 0.07% | 00.0% | Unchanged | View |
| BMYBRISTOL-MYERS SQUIBB CO COM | Stock | 2,000 | $115.24K | 0.06% | −11,622−85.3% | Reduced | View |
| EBCEASTERN BANKSHARES INC | COM | 5,000 | $111.2K | 0.06% | 00.0% | Unchanged | View |
| GOOGLALPHABET INC CAP STK CL A | Stock | 300 | $107.21K | 0.06% | 00.0% | Unchanged | View |
| LEGHLEGACY HOUSING CORP | COM | 4,000 | $105.08K | 0.06% | 00.0% | Unchanged | View |
| CTVACORTEVA INC COM | Stock | 1,206 | $102.14K | 0.05% | 00.0% | Unchanged | View |
| ISHARES RUSSELL MID-CAP GROWTH ETF464287481 | ETF | 695 | $101.76K | 0.05% | 00.0% | Unchanged | – |
| URIUNITED RENTALS INC | COM | 78 | $88.37K | 0.05% | 00.0% | Unchanged | View |
| IVVDINVIVYD INC | COM | 100,000 | $87.24K | 0.05% | 00.0% | Unchanged | View |
| AMZNAMAZON COM INC COM | Stock | 300 | $71.5K | 0.04% | 00.0% | Unchanged | View |
| DHRDANAHER CORP DEL COM | Stock | 180 | $34.29K | 0.02% | 00.0% | Unchanged | View |
| DOWDOW HLDGS INC COM | Stock | 1,206 | $33K | 0.02% | 00.0% | Unchanged | View |
| FSKFS KKR CAP CORP | COM | 2,875 | $30.19K | 0.02% | +2,875 | New | View |
| BRSLBRIGHTSTAR LOTTERY PLC | SHS USD | 2,500 | $26.8K | 0.01% | 00.0% | Unchanged | View |
| BXBLACKSTONE INC | COM | 210 | $24.71K | 0.01% | 00.0% | Unchanged | View |
| UNHUNITEDHEALTH GROUP INC COM | Stock | 57 | $23.69K | 0.01% | 00.0% | Unchanged | View |
| OXYOCCIDENTAL PETE CORP COM | Stock | 469 | $22.78K | 0.01% | −194−29.3% | Reduced | View |
| TMOTHERMO FISHER SCIENTIFIC INC COM | Stock | 45 | $22.56K | 0.01% | 00.0% | Unchanged | View |
| CRMSALESFORCE INC COM | Stock | 77 | $12.06K | 0.01% | 00.0% | Unchanged | View |
| STWDSTARWOOD PPTY TR INC | COM | 400 | $6.55K | 0.00% | 00.0% | Unchanged | View |
| KDKYNDRYL HLDGS INC COMMON STOCK | Stock | 428 | $4.84K | 0.00% | 00.0% | Unchanged | View |
| OCCIDENTAL PETE CORP WT EXP 080327674599162 | Stock | 194 | $4.27K | 0.00% | +194 | New | – |
| GEHCGE HEALTHCARE TECHNOLOGIES INC COMMON STOCK | Stock | 50 | $3.2K | 0.00% | 00.0% | Unchanged | View |
| WABWABTEC COM | Stock | 6 | $1.62K | 0.00% | 00.0% | Unchanged | View |
Sold out since Q1 2026 (12)
Positions held at the end of Q1 2026 that are no longer in this filing.
| Security | Class | Shares, Q1 2026 | Value, Q1 2026 | % of portfolio, Q1 2026 |
|---|---|---|---|---|
| CATALYST PHARMACEUTICALS INC14888U101 | COM | 120,000 | $2.97M | 1.77% |
| ARCELLX INC03940C100 | COMMON STOCK | 19,433 | $2.23M | 1.33% |
| CYTKCYTOKINETICS INC | COM NEW | 23,644 | $1.56M | 0.93% |
| CENTESSA PHARMACEUTICALS PLC152309100 | SPONSORED ADS | 39,000 | $1.55M | 0.92% |
| ADMAADMA BIOLOGICS INC | COM | 60,200 | $542.4K | 0.32% |
| Biohaven Pharmaceutical Holding Co. LtdG111OE107 | Common | 60,720 | $513.69K | 0.31% |
| EOLSEVOLUS INC | COM | 99,338 | $408.28K | 0.24% |
| LENZLENZ THERAPEUTICS INC | COM | 33,732 | $308.65K | 0.18% |
| DDDUPONT DE NEMOURS INC | COM | 3,767 | $172.53K | 0.10% |
| JSPRJASPER THERAPEUTICS INC | COM NEW | 160,789 | $140.88K | 0.08% |
| MREOMEREO BIOPHARMA GROUP PLC | SPON ADS | 300,337 | $99.11K | 0.06% |
| FS KKR CAPITAL CORP302635107 | COM | 2,875 | $29.27K | 0.02% |
13F filings by quarter
| Quarter | Filed | Positions | Total value | Changes | Filing |
|---|---|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | 84 | $189.18M | vs. Q1 2026 | SEC |
| Q1 2026 | May 14, 2026 | 85 | $168.03M | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 12, 2026 | 87 | $215.94M | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 12, 2025 | 87 | $238.71M | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 11, 2025 | 85 | $220.61M | vs. Q1 2025 | SEC |
| Q1 2025 | May 12, 2025 | 84 | $211.95M | vs. Q4 2024 | SEC |
| Q4 2024 | Feb 12, 2025 | 89 | $276.52M | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 13, 2024 | 92 | $284.57M | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 12, 2024 | 99 | $250.63M | vs. Q1 2024 | SEC |
| Q1 2024 | May 14, 2024 | 106 | $282.75M | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 13, 2024 | 113 | $261.64M | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 13, 2023 | 132 | $261.93M | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 11, 2023 | 149 | $251.27M | vs. Q1 2023 | SEC |
| Q1 2023 | May 11, 2023 | 150 | $254.49M | vs. Q4 2022 | SEC |
| Q4 2022 | Feb 13, 2023 | 174 | $264.67M | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 10, 2022 | 184 | $236.16M | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 11, 2022 | 188 | $238.14M | vs. Q1 2022 | SEC |
| Q1 2022 | May 16, 2022 | 140 | $313.96M | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 11, 2022 | 132 | $288.33M | – | SEC |